第一单位：
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
作者：
Shuying S,Li [1]
;
Peter B,Gilbert [2]
;
Lindsay N,Carpp [1]
;
Chul-Woo,Pyo [3]
;
Holly,Janes [1]
;
Youyi,Fong [2]
;
Xiaoying,Shen [4]
;
Scott D,Neidich [4]
;
Derrick,Goodman [4]
;
Allan,deCamp [1]
;
Kristen W,Cohen [1]
;
Guido,Ferrari [5]
;
Scott M,Hammer [6]
;
Magdalena E,Sobieszczyk [6]
;
Mark J,Mulligan [7]
;
Susan P,Buchbinder [8]
;
Michael C,Keefer [9]
;
Edwin,DeJesus [10]
;
Richard M,Novak [11]
;
Ian,Frank [12]
;
M Juliana,McElrath [1]
;
Georgia D,Tomaras [13]
;
Daniel E,Geraghty [14]
;
Xinxia,Peng [15]
作者单位：
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
[1]
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.;Department of Biostatistics, University of Washington, Seattle, Washington, USA.
[2]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
[3]
Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.
[4]
Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.;Department of Surgery, Duke University, Durham, North Carolina, USA.;Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.
[5]
Division of Infectious Diseases, Columbia University College of Physicians and Surgeons, New York, New York, USA.
[6]
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
[7]
Department of Medicine, University of California, San Francisco, California, USA.;Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.
[8]
Division of Infectious Diseases, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
[9]
Orlando Immunology Center, Orlando, Florida, USA.
[10]
University of Illinois at Chicago, Chicago, Illinois, USA.
[11]
Division of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
[12]
Duke Human Vaccine Institute, Duke University, Durham, North Carolina, USA.;Department of Surgery, Duke University, Durham, North Carolina, USA.;Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA.;Department of Immunology, Duke University, Durham, North Carolina, USA.
[13]
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA geraghty@fredhutch.org xpeng5@ncsu.edu.
[14]
Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, North Carolina, USA geraghty@fredhutch.org xpeng5@ncsu.edu.;Bioinformatics Research Center, North Carolina State University, Raleigh, North Carolina, USA.
[15]
医学主题词
抗体, 单克隆(Antibodies, Monoclonal);B-淋巴细胞(B-Lymphocytes);CD8阳性T淋巴细胞(CD8-Positive T-Lymphocytes);病例对照研究(Case-Control Studies);临床试验, Ⅱ期(主题)(Clinical Trials, Phase II as Topic);遗传载体(Genetic Vectors);HIV感染(HIV Infections);HIV血清阳性(HIV Seropositivity);HIV-1(HIV-1);人类(Humans);发病率(Incidence);吞噬作用(Phagocytosis);多态性, 单核苷酸(Polymorphism, Single Nucleotide);受体, IgG(Receptors, IgG);美国(United States);接种(Vaccination);疫苗, DNA(Vaccines, DNA);env基因产物, 人免疫缺陷病毒(env Gene Products, Human Immunodeficiency Virus)
DOI
10.1128/JVI.02041-18
PMID
31434737
发布时间
2024-09-22
换一批
